Mental Health Clinics in Ventnor City, NJ Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Newmind Psychology Services Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 6601 Ventnor Ave, Ste 16 B, Ventnor City, NJ 08406 Phone: 269-876-9694 |
Making Waves Aba Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 108 N Rosborough Ave, Ventnor City, NJ 08406 Phone: 856-625-6975 |
Surfside Recovery Services Inc. Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 3 S Weymouth Ave, Ventnor City, NJ 08406 Phone: 609-709-0245 |
News Archive
Freeze-dried gene therapy system safe and effective for treating brain cancer
Researchers at the Johns Hopkins University School of Medicine have developed a technique that delivers gene therapy into human brain cancer cells using nanoparticles that can be freeze-dried and stored for up to three months prior to use. The shelf-stable particles may obviate the need for virus-mediated gene therapy, which has been associated with safety concerns.
Sebelius disputes 'rate shock,' assures exchanges' readiness
Health and Human Services Secretary Kathleen Sebelius said in a call with reporters yesterday that the agency is "on target" to open new online marketplaces Oct. 1. She also spoke about personal "Obamacare" accounts which consumers can begin creating now in advance of being able to shop for plans.
PGXL to utilize AutoGenomics' automated INFINITI analyzer for personalized medicine applications
PGXL Labs, an internationally recognized pioneer in personalized medicine testing, announced today that it has established a collaborative partnership with AutoGenomics, Inc. wherein they will utilize the automated INFINITI® analyzer for several different personalized medicine applications.
FDA approves Neuralstem's IND to initiate NSI-189 Phase Ia safety trial in major depression
Neuralstem, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate a Phase Ia safety trial to test NSI-189, its first small molecule compound, in major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases, such as Alzheimer's disease.
› Verified 1 days ago